West Pharmaceutical Services (WST) Gains from Investment Securities (2016 - 2026)
West Pharmaceutical Services has reported Gains from Investment Securities over the past 18 years, most recently at -$1.0 million for Q1 2026.
- Quarterly Gains from Investment Securities fell 140.0% to -$1.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$3.5 million through Mar 2026, up 76.67% year-over-year, with the annual reading at $5.7 million for FY2024, 60.14% down from the prior year.
- Gains from Investment Securities was -$1.0 million for Q1 2026 at West Pharmaceutical Services, down from -$800000.0 in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $25.9 million in Q4 2023 and troughed at -$17.5 million in Q4 2024.
- The 5-year median for Gains from Investment Securities is $100000.0 (2024), against an average of $2.3 million.
- Biggest five-year swings in Gains from Investment Securities: crashed 167.57% in 2024 and later surged 2400.0% in 2025.
- Tracing WST's Gains from Investment Securities over 5 years: stood at -$1.3 million in 2022, then soared by 2092.31% to $25.9 million in 2023, then crashed by 167.57% to -$17.5 million in 2024, then surged by 95.43% to -$800000.0 in 2025, then decreased by 25.0% to -$1.0 million in 2026.
- According to Business Quant data, Gains from Investment Securities over the past three periods came in at -$1.0 million, -$800000.0, and $800000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.